Great article about Triple-negative breast cancer, the impact on patient's lives and the tools need to win: ‘TNBC requires all the guns’ https://t.co/FEqyK2Ilyn
It was our pleasure to share some thoughts on being a diagnostic startup and what we think the future holds for Bioarray.
“At Bioarray, we want to eliminate the error and fear inherent in cancer treatment by... https://t.co/xOlIprFWIe
We echo AACR sentiments for the loss of Sen. John McCain to an aggressive form of cancer, glioblastoma. Sen McCain consistently supported medical research funded by the NIH. https://t.co/xRfBSQ11em
Honored to be recognized by @SenMurphyOffice as Innovator of the Month. The State of Conn, its many entrepreneurs, and scientists have been incredible friends to us as we bring our Triple Negative Breast Cancer Stratification Test to Market. Read more: https://t.co/Sdbv12RUaz
We are saddened by the departure of longtime advisor and Board member Michal Preminger. We offer Michal our appreciation for her tireless dedication to the company since 2012 and wishing her the best in her new endeavors.